DeSantis Damon 4
4 · INTEGRATED BIOPHARMA INC · Filed Mar 25, 2026
Research Summary
AI-generated summary of this filing
INTEGRATED BIOPHARMA (INBP) Director Damon DeSantis Receives Gift
What Happened
- Damon DeSantis, a director of Integrated Biopharma (INBP), had a total of 1,363,685 shares transferred to an entity he controls. On 2026-03-24 two gift transactions were reported: 1,356,293 shares (price $0.00) and 7,392 shares (price $0.00), each recorded as a gift (transaction code G). Reported value for both transactions is $0.
Key Details
- Transaction date: 2026-03-24; Form 4 filed: 2026-03-25 (timely filing).
- Transaction type/code: Gift (G); reported price per share: $0.00; total reported value: $0.
- Shares transferred: 1,356,293 from CD Financial, LLC (Footnote F1) and 7,392 from the Carl DeSantis Revocable Trust (Footnote F2).
- Recipient: CDDS 2.0, LLC, a Florida LLC controlled by Damon DeSantis (per footnotes).
- Shares owned after the transaction: not specified in the supplied filing details.
Context
- These were internal transfers/gifts into an LLC controlled by the reporting person, not open‑market purchases or sales. Gifts and intra‑entity transfers do not necessarily reflect the insider’s view of the company’s stock price. No options were exercised and no cash changed hands in these reported entries.
Insider Transaction Report
Form 4
DeSantis Damon
Director
Transactions
- Gift
Common Stock
[F1]2026-03-24+1,356,293→ 1,356,293 total(indirect: By LLC) - Gift
Common Stock
[F2]2026-03-24+7,392→ 1,363,685 total(indirect: By LLC)
Footnotes (2)
- [F1]Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.
- [F2]Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.
Signature
/s/ Damon DeSantis|2026-03-25